Stefano Giuntini
University of Florence
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stefano Giuntini.
Angewandte Chemie | 2016
Enrico Ravera; Silvia Ciambellotti; Linda Cerofolini; Tommaso Martelli; Tatiana Kozyreva; Caterina Bernacchioni; Stefano Giuntini; Marco Fragai; Paola Turano; Claudio Luchinat
PEGylated proteins are widely used in biomedicine but, in spite of their importance, no atomic-level information is available since they are generally resistant to structural characterization approaches. PEGylated proteins are shown here to yield highly resolved solid-state NMR spectra, which allows assessment of the structural integrity of proteins when PEGylated for therapeutic or diagnostic use.
Journal of Biological Inorganic Chemistry | 2018
Linda Cerofolini; Tommaso Staderini; Stefano Giuntini; Enrico Ravera; Marco Fragai; Giacomo Parigi; Roberta Pierattelli; Claudio Luchinat
Paramagnetic NMR data can be profitably incorporated in structural refinement protocols of metalloproteins or metal-substituted proteins, mostly as distance or angle restraints. However, they could in principle provide much more information, because the magnetic susceptibility of a paramagnetic metal ion is largely determined by its coordination sphere. This information can in turn be used to evaluate changes occurring in the coordination sphere of the metal when ligands (e.g.: inhibitors) are bound to the protein. This gives an experimental handle on the molecular structure in the vicinity of the metal which falls in the so-called blind sphere. The magnetic susceptibility anisotropy tensors of cobalt(II) and nickel(II) ions bound to human carbonic anhydrase II in free and inhibited forms have been determined. The change of the magnetic susceptibility anisotropy is directly linked to the binding mode of different ligands in the active site of the enzyme. Indication about the metal coordination sphere in the presence of an inhibitor in pharmaceutically relevant proteins could be important in the design of selective drugs with a structure-based approach.
Nucleic Acids Research | 2017
Preet Lal; Linda Cerofolini; Vito G. D’Agostino; Chiara Zucal; Carmelo Fuccio; Isabelle Bonomo; Erik Dassi; Stefano Giuntini; Danilo Di Maio; Vikalp Vishwakarma; Ranjan Preet; Sha Neisha Williams; Max S. Fairlamb; Rachel Munk; Elin Lehrmann; Kotb Abdelmohsen; Saioa R. Elezgarai; Claudio Luchinat; Ettore Novellino; Alessandro Quattrone; Emiliano Biasini; Leonardo Manzoni; Myriam Gorospe; Dan A. Dixon; Pierfausto Seneci; Luciana Marinelli; Marco Fragai; Alessandro Provenzani
Abstract The Human antigen R protein (HuR) is an RNA-binding protein that recognizes U/AU-rich elements in diverse RNAs through two RNA-recognition motifs, RRM1 and RRM2, and post-transcriptionally regulates the fate of target RNAs. The natural product dihydrotanshinone-I (DHTS) prevents the association of HuR and target RNAs in vitro and in cultured cells by interfering with the binding of HuR to RNA. Here, we report the structural determinants of the interaction between DHTS and HuR and the impact of DHTS on HuR binding to target mRNAs transcriptome-wide. NMR titration and Molecular Dynamics simulation identified the residues within RRM1 and RRM2 responsible for the interaction between DHTS and HuR. RNA Electromobility Shifts and Alpha Screen Assays showed that DHTS interacts with HuR through the same binding regions as target RNAs, stabilizing HuR in a locked conformation that hampers RNA binding competitively. HuR ribonucleoprotein immunoprecipitation followed by microarray (RIP-chip) analysis showed that DHTS treatment of HeLa cells paradoxically enriched HuR binding to mRNAs with longer 3′UTR and with higher density of U/AU-rich elements, suggesting that DHTS inhibits the association of HuR to weaker target mRNAs. In vivo, DHTS potently inhibited xenograft tumor growth in a HuR-dependent model without systemic toxicity.
Journal of Physical Chemistry B | 2017
Linda Cerofolini; Stefano Giuntini; Alexandra Louka; Enrico Ravera; Marco Fragai; Claudio Luchinat
Solid-state NMR is becoming a powerful tool to detect atomic-level structural features of biomolecules even when they are bound to (or trapped in) solid systems that lack long-range three-dimensional order. We here demonstrate that it is possible to probe protein-ligand interactions from a protein-based perspective also when the protein is entrapped in silica, thus translating into biomolecular solid-state NMR all of the considerations that are usually made to understand the chemical nature of the interaction of a protein with its ligands. This work provides a proof of concept that also immobilized enzymes can be used for protein-based NMR protein-ligand interactions for drug discovery.
Angewandte Chemie | 2017
Stefano Giuntini; Evita Balducci; Linda Cerofolini; Enrico Ravera; Marco Fragai; Francesco Berti; Claudio Luchinat
Abstract Carbohydrate‐based vaccines are among the safest and most effective vaccines and represent potent tools for prevention of life‐threatening bacterial infectious diseases, like meningitis and pneumonia. The chemical conjugation of a weak antigen to protein as a source of T‐cell epitopes generates a glycoconjugate vaccine that results more immunogenic. Several methods have been used so far to characterize the resulting polysaccharide–protein conjugates. However, a reduced number of methodologies has been proposed for measuring the degree of saccharide conjugation at the possible protein sites. Here we show that detailed information on large proteins conjugated with large polysaccharides can be achieved by a combination of solution and solid‐state NMR spectroscopy. As a test case, a large protein assembly, l‐asparaginase II, has been conjugated with Neisseria meningitidis serogroup C capsular polysaccharide and the pattern and degree of conjugation were determined.
Scientific Reports | 2017
Stefano Giuntini; Linda Cerofolini; Enrico Ravera; Marco Fragai; Claudio Luchinat
The development of a methodology for the structural characterization at atomic detail of proteins conjugated to nanoparticles would be a breakthrough in nanotechnology. Solution and solid-state NMR spectroscopies are currently used to investigate molecules and peptides grafted onto nanoparticles, but the strategies used so far fall short in the application to proteins, which represent a thrilling development in theranostics. We here demonstrate the feasibility of highly-resolved multidimensional heteronuclear spectra of a large protein assembly conjugated to PEGylated gold nanoparticles. The spectra have been obtained by direct proton detection under fast MAS and allow for both a fast fingerprinting for the assessment of the preservation of the native fold and for resonance assignment. We thus demonstrate that the structural characterization and the application of the structure-based methodologies to proteins bound to gold nanoparticles is feasible and potentially extensible to other hybrid protein-nanomaterials.
Journal of Medicinal Chemistry | 2018
Francesco Merlino; Simona Daniele; Valeria La Pietra; Salvatore Di Maro; Francesco Saverio Di Leva; Diego Brancaccio; Stefano Tomassi; Stefano Giuntini; Linda Cerofolini; Marco Fragai; Claudio Luchinat; Florian Reichart; Chiara Cavallini; Barbara Costa; Rebecca Piccarducci; Sabrina Taliani; Federico Da Settimo; Claudia Martini; Horst Kessler; Ettore Novellino; Luciana Marinelli
In the fight against Glioblastoma Multiforme, recent literature data have highlighted that integrin α5β1 and p53 are part of convergent pathways in the control of glioma apoptosis. This observation prompted us to seek a molecule able to simultaneously modulate both target families. Analyzing the results of a previous virtual screening against murine double minute 2 protein (MDM2), we envisaged that Arg-Gly-Asp (RGD)-mimetic molecules could be inhibitors of MDM2/4. Herein, we present the discovery of compound 7, which inhibits both MDM2/4 and α5β1/αvβ3 integrins. A lead optimization campaign was carried out on 7 with the aim to preserve the activities on integrins while improving those on MDM proteins. Compound 9 turned out to be a potent MDM2/4 and α5β1/αvβ3 blocker. In p53-wild type glioma cells, 9 arrested cell cycle and proliferation and strongly reduced cell invasiveness, emerging as the first molecule of a novel class of integrin/MDM inhibitors, which might be especially useful in subpopulations of patients with glioblastoma expressing a functional p53 concomitantly with a high level of α5β1 integrin.
Chemistry: A European Journal | 2018
Cristina Nativi; Alberto Marra; Jiajia Dong; Tiancheng Ma; Stefano Giuntini; Elisa Crescenzo; Linda Cerofolini; Marco Martinucci; Claudio Luchinat; Marco Fragai; Alessandro Dondoni
Protein glycosylation is the most complex post-translational modification process. More than 50 % of human cells proteins are glycosylated, whereas bacteria such as E. coli do not have this modification machinery. Indeed, the carbohydrate residues in natural proteins affect their folding, immunogenicity, and stability toward proteases, besides controlling biological properties and activities. It is therefore important to introduce such structural modification in bioengineered proteins lacking the presence of carbohydrate residues. This is not trivial as it requires reagents and conditions compatible with the proteins stability and reactivity. This work reports on the introduction of lactose moieties in two natural proteins, namely ubiquitin (Ub) and l-asparaginase II (ANSII). The synthetic route employed is based on the sulfur(VI) fluoride exchange (SuFEx) coupling of a lactose tethered arylfluorosulfate (Lact-Ar-OSO2 F) with the ϵ-NH2 group of lysine residues of the proteins. This metal-free click SuFEx reaction relies on the properties of the fluorosulfate employed, which is easily prepared in multigram scale from available precursors and reacts chemoselectively with the ϵ-NH2 group of lysine residues under mild conditions. Thus, iterative couplings of Lact-Ar-OSO2 F to Ub and ANSII, afforded multiple glycosylations of these proteins so that up to three and four Lact-Ar-OSO2 groups were introduced in Ub and ANSII, respectively, via the formation of a sulfamoyl (OSO2 -NH) linkage.
Physical Chemistry Chemical Physics | 2018
Alexandra Louka; Irina Matlahov; Stefano Giuntini; Linda Cerofolini; Andrea Cavallo; Serena Pillozzi; Enrico Ravera; Marco Fragai; Annarosa Arcangeli; Ayyalusamy Ramamoorthy; Gil Goobes; Claudio Luchinat
Nanoscale | 2018
Gianluca Salerno; Simona Scarano; Marianna Mamusa; Marco Consumi; Stefano Giuntini; Antonella Macagnano; Stefano Nativi; Marco Fragai; Maria Minunni; Debora Berti; Agnese Magnani; Cristina Nativi; Barbara Richichi